Plasminogen activator inhibitor-1 mediate downregulation of adiponectin in type 2 diabetes patients with metabolic syndrome

INTRODUCTION: Metabolic syndrome (MetS) is a multifactorial disease characterized by metabolic abnormalities. Plasminogen activator inhibitor-1(PAI-1) is a key factor of the fibrinolysis its expression is elevated in insulin resistance, obesity, and MetS. In addition, an adiponectin produced by adip...

Descripción completa

Detalles Bibliográficos
Autores principales: Nawaz, Shaik Sarfaraz, Siddiqui, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803603/
https://www.ncbi.nlm.nih.gov/pubmed/35128381
http://dx.doi.org/10.1016/j.cytox.2022.100064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803603/
https://www.ncbi.nlm.nih.gov/pubmed/35128381
http://dx.doi.org/10.1016/j.cytox.2022.100064

Ejemplares similares